Meeting
2014 ASCO Annual Meeting
Expansion of peptide-specific T cells from human melanoma-draining lymph nodes.
Authors
Madeleine Strohl
Case Western Reserve University School of Medicine, Cleveland, OH
Madeleine Strohl , Hallie Graor , Mei Zhang , Anthony Visioni , John Brian Ammori , Isabelle Rivers-McCue , Julian Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Immunotherapy
Track
Developmental Therapeutics
Sub Track
Immunotherapy and Biologic Therapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3047)
DOI
10.1200/jco.2014.32.15_suppl.3047
Abstract #
3047
Poster Bd #
114
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.
First Author: Rongsu Qi
Poster
2016 ASCO Annual Meeting
A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM).
First Author: Rodabe Navroze Amaria
Poster
2015 ASCO Annual Meeting
Analysis of CTLA4 expression on T regulatory cells in patients with advanced stage melanoma in the setting of high dose IL-2 (HDIL-2).
First Author: Maggie L. Diller
Poster
2015 ASCO Annual Meeting
The effect of ipilimumab on natural killer cells identifies the subset of advanced melanoma patients with clinical response.
First Author: Ines Esteves Domingues Pires Da Silva